How Much Psilocybin Is the Right Dose? Why the Answer Depends on More Than Grams
The science of psilocybin dosage — and why what happens before and after the ceremony matters as much as the number on the scale.
The question everyone asks — and why it's harder to answer than it looks
Before almost every ceremony, someone asks the same question.
How much will I take?
It makes sense. You are about to do something unfamiliar. You want to understand what you are walking into. And dosage feels like the part of this you can pin down — a number, a weight, something concrete in an experience that is, by definition, hard to predict.
The honest answer is: it depends. Not as a way of dodging the question. But because the research — and years of facilitated practice — make clear that the dose in grams is only one variable in a much more complex equation.
This post lays out what the science actually says, what the numbers mean in practice, and why the same 20 grams of psilocybin truffles can produce two completely different experiences in two different people — or even in the same person, on two different days.
First, the numbers
Psilocybin truffles are measured by fresh weight. The active compound — psilocybin — makes up roughly 0.75 to 1.75 mg per gram of fresh truffle, depending on the strain, cultivation conditions, and batch. Which already tells you something: weight is an approximation, not a precise dosage.
In broad terms, the categories used across clinical research and retreat practice look like this:
Microdose: 0.5–2g fresh truffles. Sub-perceptual. No altered state. Used in structured protocols to support neuroplasticity and mood over time.
Low dose: 5–10g fresh truffles. Mild perceptual shifts. Heightened sensory awareness, emotional openness. The kind of experience you remain fully present for, with no loss of orientation.
Moderate dose: 10–20g fresh truffles. This is the therapeutic range — where most of the clinical research sits, and where most guided ceremonies operate. Clear perceptual and emotional effects. Potential for significant insight. You feel it, fully.
High dose: 20–35g fresh truffles. Intense. Ego dissolution can become possible. Time perception breaks down. This is not where you start — and not where you go without a container you trust.
In clinical trials, psilocybin is measured differently — in milligrams of pure synthetic compound, administered at weights typically between 20–30mg for a 70kg person. The Johns Hopkins depression studies used 25mg and 30mg doses. To give a rough sense of equivalence: 25mg of synthetic psilocybin corresponds to approximately 14–33g of fresh truffles, depending on the batch.
Which already shows you why a single number can't tell the whole story.
What the research says about dose and outcome
The clinical data on psilocybin is striking — not just because the outcomes are significant, but because of what predicts them.
A 2016 study at Johns Hopkins — one of the most cited in the field — found that higher doses produced stronger mystical experiences, and that the intensity of the mystical experience was the single strongest predictor of lasting positive change. More dose, more depth, better outcomes.
But here is what that framing misses.
Every participant in that study received the same preparation. The same integration support. The same carefully held setting. The dose variable was isolated — everything else was controlled and structured.
In a 2023 study of 608 people who used psilocybin outside of guided settings, roughly one third were still struggling with difficult aftereffects more than a year later. Dose wasn't the protective factor. The presence of professional support during and after the experience was.
Same compound. Different containers. Completely different outcomes.
…the strongest predictor of lasting benefit at six months wasn't the dose — it was the rate of ongoing meditation and spiritual practice in the weeks following the session. The dose opened the window. The practice determined what was built inside it.
Why the same dose lands differently in different people
This is where it gets genuinely interesting — and where the gram count becomes almost beside the point.
Individual neurophysiology varies considerably. Psilocybin is metabolized into psilocin primarily in the gut and liver. Differences in gut enzyme activity, serotonin receptor sensitivity, and baseline brain states mean that two people of similar weight can have dramatically different responses to identical doses. There is some evidence that body weight matters at the extremes — researchers have used weight-adjusted protocols — but multiple studies have found it to be a weaker predictor than expected.
Mental state at the time of ingestion shapes the experience more than almost anything else. Psilocybin amplifies what is already present. Someone arriving exhausted and anxious, without preparation, will have a very different journey than someone who has spent weeks clarifying intention and building inner resources — even at the same dose.
The setting is pharmacologically relevant. This is not metaphor. A foundational review by Carhart-Harris and Friston on the REBUS model of psychedelic action proposes that psilocybin works by relaxing the brain's prior beliefs — making it more responsive to bottom-up information from the environment. Which means the environment, literally, becomes part of the drug's effect. Music, light, the quality of the relationship with the facilitator, the sense of safety — these aren't decoration. They are inputs.
Prior experience with psychedelics matters — but not always in the direction people expect. Tolerance to psilocybin builds rapidly with repeated use and dissipates within days. Someone who used psychedelics frequently in the past may find a moderate dose underwhelming. Someone with no prior experience may find the same dose more intense than anticipated. And sometimes the opposite happens: a highly experienced person encounters something in a moderate dose that a larger dose never reached.
How dosage decisions are made in a guided ceremony
In a responsible facilitated context, the dose conversation begins well before the ceremony — and it never ends with a single number.
The process typically involves a medical and psychological screening: understanding current medications (SSRIs, in particular, can blunt psilocybin's effects significantly, sometimes requiring a higher dose to achieve the same depth), mental health history, current life circumstances, and sleep and nutrition in the days before.
It involves a conversation about intention. What someone is carrying into the ceremony shapes what the medicine is likely to surface. A person working through grief may need a different container than someone exploring consciousness out of curiosity — even if the numbers on the scale look the same.
It involves reading the person in the room. A facilitator's job on the day of the ceremony includes noticing how someone arrives — their nervous system state, their openness, what they are holding. The dose decision is a conversation, not a prescription.
And it often involves a split approach: an initial dose, with time to feel it settle before considering a supplement. This allows the experience to unfold at its own pace, rather than front-loading an intensity the person hasn't yet oriented to.
The part that doesn't show up in the dosage guide
Here is what almost every dosage article leaves out.
The research is consistent: what happens after the dose matters as much as the dose itself.
In a 2018 study by Griffiths and colleagues, the strongest predictor of lasting benefit at six months wasn't the dose — it was the rate of ongoing meditation and spiritual practice in the weeks following the session. The dose opened the window. The practice determined what was built inside it.
Psilocybin produces a period of heightened neuroplasticity after the ceremony — a window, roughly two to four weeks, during which the brain is more receptive to new patterns. What you do with that window is, in many ways, the real dosage question.
A high dose with no integration is a powerful experience that often fades.
A moderate dose inside a well-held container — with preparation, with professional support during the ceremony, with structured integration afterward — is where the clinical outcomes that have generated so much attention actually come from.
The number on the scale is the beginning of the conversation. Not the answer.
Post by co-founder Ioana
Ioana is a researcher, psychedelic facilitator, and coach whose work sits at the intersection of science, embodiment, and lived experience. She spent years inside academia studying psychedelics, health and wellbeing — and eventually decided the most useful thing she could do with that knowledge was bring it into the room with people, not just onto the page. These posts are her attempt to make psychedelic science accessible and honest — without flattening it into wellness copy or drowning it in jargon.
At Hearts Door Retreats, integration is built into every ceremony we offer. We provide an integration guide tailored to what arose in your experience — because the window the ceremony creates is real, and we want to help you use it well. Our next Foundation Retreat is 9–12 July in the Netherlands. If you're curious, we are glad to talk. Read about our work here
